Reshma Kewalramani is Director of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 186,002 shares of DNA, which is worth approximately $1.87 Million. The most recent transaction as insider was on Jun 12, 2024, when has been sold 105,263 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 186K
0% 3M change
130.37% 12M change
Total Value Held $1.87 Million

Reshma Kewalramani Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Exercise of conversion of derivative security
-
105,263 Added 36.14%
186,002 Class A Common Stock
Sep 30 2022
BUY
Exercise of conversion of derivative security
-
9,818 Added 10.84%
80,739 Class A Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
70,921 Added 50.0%
70,921 Class A Common Stock

Also insider at

VRTX
VERTEX PHARMACEUTICALS INC Healthcare
RK

Reshma Kewalramani

Director
Boston, MA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA